Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14061287
Abstract: Mitochondrial diseases (MDs) are a group of severe genetic disorders caused by mutations in the nuclear or mitochondrial genome encoding proteins involved in the oxidative phosphorylation (OXPHOS) system. MDs have a wide range of symptoms,… read more here.
Keywords: mitochondrial diseases; gene therapy; therapy mitochondrial; gene ... See more keywords